Every Form 4 that Walker & Dunlop, Inc. (WD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow WD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WD filings page.
Walker & Dunlop, Inc. (symbol: WD) is the issuer of record for a Form 4 filing submitted to the SEC. THEOBALD STEPHEN P reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. executive Stephen P. Theobald, EVP & Chief Operating Officer, received an award of 151.473 Dividend Equivalent Rights on September 3, 2026. Each right is economically equivalent to one share of common stock and relates to restricted stock units, bringing his directly held dividend equivalent rights to 1,707.336.
Walker William M reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. (WD) reported that Chairman & CEO William M. Walker received a grant of 50.288 dividend equivalent rights on September 3, 2026, tied to his existing restricted stock units. Following this award, he holds a total of 242.1064 dividend equivalent rights, each economically equivalent to one share of common stock and vesting proportionately with the related restricted stock units.
Walker & Dunlop, Inc. (symbol: WD) is the issuer of record for a Form 4 filing submitted to the SEC. Pryor Paula A. reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. (WD) reported that Paula A. Pryor, EVP and Chief HR Officer, received a grant of 51.784 Dividend Equivalent Rights on September 3, 2026. Each right is economically equivalent to one share of common stock and accrued on restricted stock units, vesting proportionately with those units. Following this award, Pryor holds 207.415 Dividend Equivalent Rights directly. No Rule 10b5-1 trading plan is reported for this transaction.
Walker & Dunlop, Inc. (symbol: WD) is the issuer of record for a Form 4 filing submitted to the SEC. Groman Daniel J reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. reported that executive officer Daniel J. Groman, EVP, General Counsel, Secretary and Chief Compliance Officer, received an award of 122.824 Dividend Equivalent Rights on September 3, 2026. Each right is the economic equivalent of one share of Walker & Dunlop common stock and relates to restricted stock units held by him. These rights accrue as dividends are paid and vest proportionately with the underlying restricted stock units. Following this award, Mr. Groman directly holds a total of 505.769 Dividend Equivalent Rights. No transactions are reported under a Rule 10b5-1 trading plan.
Walker & Dunlop, Inc. (symbol: WD) is the issuer of record for a Form 4 filing submitted to the SEC. Florkowski Gregory reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. reported that its EVP & Chief Financial Officer, Gregory Florkowski, received a grant of 85.221 dividend equivalent rights on September 3, 2026. Each right is the economic equivalent of one share of common stock and relates to previously granted restricted stock units.
Following this award, Florkowski holds a total of 333.226 dividend equivalent rights directly. These rights accrue on his restricted stock units and vest proportionately with the underlying units. No Rule 10b5-1 trading plan is reported for this transaction.
THEOBALD STEPHEN P reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop EVP & Chief Operating Officer Stephen P. Theobald received a grant of dividend equivalent rights tied to his existing equity awards. On June 4, 2026, he was awarded 120.612 dividend equivalent rights, each economically equivalent to one share of common stock.
These rights accrued on restricted stock units he already holds and will vest proportionately with those units over time, rather than immediately. Following this grant, he holds a total of 1,555.863 dividend equivalent rights directly, reflecting routine, compensation-related equity accrual rather than an open-market stock purchase or sale.
Walker & Dunlop, Inc. executive Paula A. Pryor, EVP and Chief HR Officer, reported an acquisition of 41.234 dividend equivalent rights on June 4, 2026. Each right is economically equivalent to one share of common stock and is tied to existing restricted stock units, bringing her total dividend equivalent rights to 155.631.
Walker & Dunlop, Inc. executive Daniel J. Groman reported an acquisition of 97.799 dividend equivalent rights tied to his existing restricted stock units. Each right is economically equivalent to one share of common stock and will vest proportionately with the related restricted stock units, bringing his reported balance to 382.945 dividend equivalent rights.
Florkowski Gregory reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop EVP & CFO Gregory Florkowski reported a routine compensation-related transaction. He received 67.857 dividend equivalent rights on June 4, 2026, each economically equivalent to one share of common stock. These rights accrued on his existing restricted stock units and will vest proportionately with those units. Following this grant, he directly holds 248.005 dividend equivalent rights. This is not an open-market stock purchase or sale, but an automatic award tied to prior equity grants.
Walker William M reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. reported that Chairman & CEO William M. Walker received a grant of 40.042 dividend equivalent rights on June 4, 2026. Each right is economically equivalent to one share of common stock and accrued on restricted stock units he holds.
After this award, Walker holds a total of 191.8184 dividend equivalent rights. These rights vest proportionately with the related restricted stock units, meaning they follow the same vesting schedule rather than being immediately exercisable.
Wells Donna reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. director Donna Wells received a grant of 3,096 deferred stock units. Each unit represents the right to receive one share of Walker & Dunlop common stock. The units vest on the one-year anniversary of the grant date and will be settled in common shares under the company’s Deferred Compensation Plan for Non-Employee Directors.
Walker & Dunlop director Dana L. Schmaltz received equity awards in the form of common stock and deferred stock units. Schmaltz was granted 3,096 shares of restricted common stock under the Walker & Dunlop, Inc. 2024 Equity Incentive Plan, which vest on the one-year anniversary of the grant date. In addition, Schmaltz acquired 2,477 deferred stock units, each representing the right to receive one share of Walker & Dunlop common stock, which are fully vested and will be settled in shares under the company’s Deferred Compensation Plan for Non-Employee Directors. Following these awards, Schmaltz directly holds 87,421 shares of common stock and 2,477 deferred stock units.
Rice E. John Jr reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop director John E. Rice Jr. received a grant of 3,096 shares of restricted common stock as compensation under the company’s 2024 Equity Incentive Plan. These shares vest on the one-year anniversary of the grant date. After this award, he directly owns 36,397 common shares and indirectly holds 55 shares through a trust.
Pinkus Gary S reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop director Gary S. Pinkus received a grant of 3,096 deferred stock units. These units were awarded at no cash cost as director compensation and each unit represents one share of common stock. The award will vest on the one-year anniversary of the grant date and then be settled in Walker & Dunlop common shares in accordance with the company’s Deferred Compensation Plan for Non-Employee Directors.
Levy Ellen reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. director Ellen Levy reported receiving a grant of 3,096 deferred stock units on common stock. These units were awarded as compensation, with no cash paid by Levy for the grant. Following the award, she holds 3,096 deferred stock units directly.
Each deferred stock unit represents the right to receive one share of Walker & Dunlop common stock. The units vest on the one-year anniversary of the grant date and will be settled in common shares in accordance with the company’s Deferred Compensation Plan for non‑employee directors.
Hayward Jeffery R reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. director Jeffery R. Hayward received a grant of 3,096 shares of common stock at no cost as equity compensation. The award was made under the Walker & Dunlop, Inc. 2024 Equity Incentive Plan and consists of restricted common stock that vests on the one-year anniversary of the grant date. Following this grant, Hayward directly holds 6,712 shares of Walker & Dunlop common stock.
FREEDMAN ERNEST MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. director Ernest Michael Freedman reported receiving a grant of 3,096 shares of common stock as equity compensation. These shares are described as restricted common stock issued under the Walker & Dunlop, Inc. 2024 Equity Incentive Plan and will vest on the one-year anniversary of the grant date. Following this award, Freedman directly holds 9,193 shares of Walker & Dunlop common stock.
Walker William M reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. Chairman & CEO William M. Walker received a grant of 47.3310 dividend equivalent rights on Common Stock. Each right is the economic equivalent of one share of common stock and accrued on restricted stock units, vesting proportionately with those units. Following this award, Walker holds a total of 151.7764 dividend equivalent rights.
Walker & Dunlop EVP and General Counsel Daniel J. Groman received a grant of dividend equivalent rights tied to existing equity awards. On this Form 4, he acquired 115.601 dividend equivalent rights, each economically equal to one share of Walker & Dunlop common stock. These rights accrued on restricted stock units he already holds and will vest over time in step with those underlying restricted stock units. Following this grant, his directly held dividend equivalent rights total 285.146, reflecting routine, compensation-related adjustments rather than open-market trading.
Walker & Dunlop EVP and Chief HR Officer Paula A. Pryor received a routine equity-related award. On March 27, she acquired 48.740 dividend equivalent rights tied to existing restricted stock units, with each right economically equivalent to one share of common stock.
The dividend equivalent rights accrued on her restricted stock units and will vest proportionately with those units. Following this grant, she holds a total of 114.397 dividend equivalent rights, reflecting additional stock-based compensation rather than an open-market purchase or sale.
THEOBALD STEPHEN P reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. executive Stephen P. Theobald, EVP & Chief Operating Officer, received a grant of dividend equivalent rights tied to his existing equity awards. The award covers 142.566 dividend equivalent rights, each economically equivalent to one share of common stock.
These dividend equivalent rights accrued on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. Following this grant, he holds a total of 1,435.251 dividend equivalent rights directly.
Florkowski Gregory reported acquisition or exercise transactions in this Form 4 filing.
Walker & Dunlop, Inc. executive vice president and chief financial officer Gregory Florkowski received a grant of 80.2100 Dividend Equivalent Rights on March 27, 2026. Each right is economically equivalent to one share of common stock and was credited in connection with restricted stock units he already holds.
Following this grant, Florkowski holds a total of 180.1480 dividend equivalent rights directly. These rights accrue as the company pays dividends and will vest on the same schedule and in the same proportions as the related restricted stock units.
Walker & Dunlop, Inc. director Dana L. Schmaltz purchased 1,000 shares of common stock in an open-market transaction at a price of $45.7800 per share. Following this buy, Schmaltz directly owns 84,325 shares of Walker & Dunlop common stock.
Walker & Dunlop director Dana L. Schmaltz exercised deferred stock units into common shares. On March 13, 2026, Schmaltz converted 1105 deferred stock units into 1105 shares of common stock at a stated price of $0.00 per share under the company’s Deferred Compensation Plan for Non-Employee Directors.
Following this compensation-related exercise, Schmaltz holds 83325 shares of Walker & Dunlop common stock directly. The deferred stock units were fully vested and represent one share of common stock each, and no shares were reported as sold in this filing.
Walker & Dunlop director Donna Wells exercised deferred stock units into common shares. On March 13, 2026, she converted 1,381 fully vested deferred stock units into 1,381 shares of Walker & Dunlop common stock under the company’s Deferred Compensation Plan for Non-Employee Directors, bringing her direct holdings to 6,658 shares.
Walker & Dunlop director Ernest Michael Freedman reported an open-market purchase of 5,000 shares of common stock on March 5, 2026 at a weighted average price of $49.2087 per share, executed in multiple trades between $49.076 and $49.3499. Following this purchase, he directly owns 6,097 shares of Walker & Dunlop common stock.
Walker & Dunlop director Donna Wells reported an open-market purchase of 500 shares of common stock at $46.96 per share on March 3, 2026. Following this transaction, she directly owns 5,277 common shares of the company.
Walker & Dunlop Chairman and CEO William M. Walker reported an open-market purchase of 10,000 shares of the company’s common stock. The shares were bought on March 2, 2026 at a weighted average price of $47.4632 per share, across multiple trades between $47.19 and $47.68.
After this purchase, Walker directly owns 488,948.192 shares of Walker & Dunlop common stock. The filing also lists additional indirect holdings through Walker Family Holdings LLC and as custodian for three sons, which reflect ownership structure rather than new transactions.
Walker & Dunlop EVP & CFO Gregory Florkowski reported multiple equity awards and a related tax share disposition. On February 13, 2026, he acquired 5,492 Deferred Stock Units, each representing one share of common stock, which are fully vested and will be settled in shares under the company’s deferred stock plan.
He also received 2,746 Restricted Stock Units, vesting in three equal annual installments beginning on February 15, 2027, and 12,124 shares of common stock as a grant, all at a stated price of $0.00 per share. On the same date, 2,883 shares of common stock were disposed of at $61.86 per share to satisfy tax withholding obligations, leaving him with 37,862.107 directly owned common shares.
Walker & Dunlop, Inc. Chairman and CEO William M. Walker reported a stock award and a related tax-withholding share disposition. He received a grant of 48,496 shares of common stock at a stated price of $0.00 per share, increasing his direct holdings before tax withholding. According to the footnote, this restricted stock vests in three equal annual installments beginning on February 15, 2027.
To cover tax obligations, 9,940 shares of common stock were disposed of at $61.86 per share through a tax-withholding transaction, leaving Walker with 478,948.192 directly held shares afterward. The filing also lists indirect holdings, including 540,147 shares held by Walker Family Holdings LLC and 3,955 shares held as custodian for each of three sons.
Walker & Dunlop, Inc. Executive Vice President and Chief Operating Officer Stephen P. Theobald reported equity compensation activity in company common stock. He received a grant of 16,973 shares of restricted stock at a stated price of $0.00 per share, which vest in three equal annual installments beginning on February 15, 2027. To cover tax obligations, 3,273 shares were disposed of at a price of $61.86 per share through a tax-withholding transaction, rather than an open-market sale. Following these transactions, he directly owned 81,551.137 common shares and indirectly held 38,219 shares through a family LLC.
Walker & Dunlop EVP and Chief HR Officer Paula A. Pryor reported new equity awards and related tax withholding transactions. On February 13, 2026, she acquired 2,405 Deferred Stock Units, 1,202 Restricted Stock Units, and 8,082 shares of Common Stock as grants at a stated price of $0.0000 per share.
Each deferred and restricted stock unit represents the right to receive one share of common stock. The deferred stock units are fully vested and will be settled in shares under the company’s Management Deferred Stock Unit Purchase Plan. The restricted stock vests in three equal annual installments beginning on February 15, 2027. On the same date, 2,169 shares of common stock were disposed of at $61.86 per share to satisfy tax liabilities, leaving her with 15,253.558 shares of common stock directly owned.
Walker & Dunlop executive Daniel J. Groman, EVP, General Counsel, Secretary and Chief Compliance Officer, reported multiple equity awards and a tax-related share disposition. He acquired 6,466 deferred stock units, 3,233 restricted stock units, and 8,082 shares of common stock on February 13, 2026, all at a stated price of $0.00 per share as grant or award acquisitions.
The restricted stock vests in three equal annual installments beginning on February 15, 2027. Each deferred stock unit and each restricted stock unit represents the right to receive one share of Walker & Dunlop common stock, with settlement timing determined under the company’s Management Deferred Stock Unit Purchase Plan. To cover tax obligations, 1,471 shares of common stock were disposed of at $61.86 per share, leaving him with 22,305.266 common shares held directly after the transactions.
William M. Walker, Chairman & CEO of Walker & Dunlop, Inc., reported equity award settlements and share movements dated January 30, 2026. He acquired 7,829.986 shares of common stock at $0.00 per share upon the settlement of deferred stock units, restricted stock units, and related dividend equivalent rights. On the same date, he disposed of 3,251 common shares at $62.89 per share. Following these transactions, he directly owned 440,392.192 common shares, with additional indirect holdings of 540,147 shares through Walker Family Holdings LLC and 3,955 shares each as custodian for three sons.
Walker & Dunlop Chairman and CEO files insider equity update
The Chairman and CEO of Walker & Dunlop, Inc. (WD), who also serves as a director, reported an equity-related transaction dated 12/05/2025. The filing shows an acquisition of 61.279 dividend equivalent rights, which are derivatives tied to the company’s common stock.
Each dividend equivalent right is the economic equivalent of one share of Walker & Dunlop common stock and accrued on restricted stock units already held by the executive. These rights vest proportionately with the related restricted stock units, at an exercise price of $0. Following this transaction, the executive directly beneficially owns 461.4314 derivative securities in the form of dividend equivalent rights linked to common shares.
Walker & Dunlop, Inc. officer EVP & Chief Operating Officer reported an equity-related transaction on 12/05/2025. The Form 4 shows the acquisition of 94.636 dividend equivalent rights, which the company states are economically equivalent to the same number of shares of its common stock.
The dividend equivalent rights were credited on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. After this transaction, the reporting person beneficially owned 1,292.685 dividend equivalent rights, held directly.
Walker & Dunlop, Inc. executive vice president and Chief HR Officer reported a routine equity-related transaction. On 12/05/2025, the officer acquired 19.75 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock. These rights accrued on restricted stock units already held by the officer and will vest proportionately with those restricted stock units.
After this transaction, the officer beneficially owned 65.657 derivative securities tied to Walker & Dunlop common stock. The dividend equivalent rights were acquired at a stated price of $0, reflecting their nature as an adjustment linked to existing restricted stock unit awards rather than an open-market purchase.
Walker & Dunlop executive reports dividend equivalent rights
Walker & Dunlop, Inc. executive officer EVP, GC, Secretary & CCO filed a Form 4 reporting an equity-related transaction on 12/05/2025. The filing shows an acquisition (code "A") of 42.837 dividend equivalent rights, each economically equivalent to one share of Walker & Dunlop common stock, at a price of $0 per right.
The dividend equivalent rights accrued on restricted stock units already held by the executive and will vest proportionately with those underlying restricted stock units. Following this transaction, the executive beneficially owns 169.545 derivative securities of this type in direct ownership form.
Walker & Dunlop, Inc. executive vice president and chief financial officer reported an equity-related transaction involving derivative securities tied to the company’s common stock. On 12/05/2025, the officer acquired 24.451 dividend equivalent rights, each economically equivalent to one share of common stock, at a price of $0.
These dividend equivalent rights accrued on restricted stock units already held and will vest proportionately with those units over time. Following this transaction, the officer beneficially owned 99.938 derivative securities directly, reflecting ongoing alignment of compensation with the company’s equity performance rather than an open-market purchase or sale.